Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
National
Miklos Bolza

FORGOTTEN HISTORY: Cheaper diabetes drug halted by astrazeneca court win - Caught on Camera

An Australian company has been restrained from listing drugs on the PBS competing with AstraZeneca. (Flavio Brancaleone/AAP PHOTOS)

Consumer hopes for a version of AstraZeneca's blockbuster diabetes drug Forxiga that doesn't hit hip pockets as hard have been dented by a court win to the pharma giant.

AstraZeneca sells a bottle of 28 tablets of Forxiga for $US25 ($A35) after federal government subsidies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.